Equities

Susmed Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
4263:TYO

Susmed Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)943.00
  • Today's Change-3.00 / -0.32%
  • Shares traded66.50k
  • 1 Year change+40.75%
  • Beta1.5861
Data delayed at least 15 minutes, as of Feb 06 2026 06:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Susmed Inc is a Japan-based company mainly engaged in the digital therapeutics (DTx) development business. The Company operates through two business segments. The DTx Product segment is engaged in the development of application software products for treating diseases such as insomnia, breast cancer, chronic kidney diseases and others. The DTx Platform segment is engaged in the provision of general-purpose clinical trial systems and machine learning automatic analysis systems, as well as the provision of DTx development support services using systems.

  • Revenue in JPY (TTM)476.59m
  • Net income in JPY-255.50m
  • Incorporated2015
  • Employees43.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Cyberlinks Co Ltd17.52bn1.26bn14.63bn786.0011.431.636.040.8351112.13112.131,551.58788.111.2618.845.7722,288,800.009.116.0612.588.0332.9530.377.225.001.4792.700.291620.375.648.7282.9223.7612.0816.27
Open Group Inc7.86bn830.51m14.89bn212.0017.051.2311.621.8913.8413.84130.92191.240.39875.223.4537,054,580.004.25-0.5316.20-0.716568.0753.7410.69-1.352.26--0.3011--17.17-6.43162.2990.49-12.67--
Feedforce Group Inc4.66bn1.31bn15.04bn194.0012.044.4010.003.2352.4252.42186.56143.330.6089--2.5124,020,620.0017.087.3029.6712.0271.7468.4028.0514.32--15.740.39629.473.4123.43111.8443.74----
Link-U Group Inc4.64bn84.84m15.45bn193.00184.706.0641.403.335.905.90326.53179.970.8203--4.2124,189,320.001.976.313.058.3547.5459.822.418.00----0.42060.0017.0027.5312.48-3.33-7.80--
Serverworks Co Ltd38.59bn-334.66m15.51bn449.00--1.4127.060.402-44.77-44.774,957.411,385.521.86--7.3085,946,780.00-1.613.82-2.875.539.5612.98-0.86722.60---11.650.05320.0029.8339.296.1115.237.23--
Ryomo Systems Co Ltd26.21bn2.11bn15.88bn1.03k7.521.064.610.6059602.10602.107,492.144,254.531.118.316.1025,423,690.008.915.8512.307.8523.8225.878.046.132.3261.080.232511.1723.757.2566.1112.71-8.2118.47
Susmed Inc476.59m-255.50m15.91bn43.00--3.73--33.38-15.20-15.2028.36253.040.1042--33.6211,083,510.00-5.59-6.38-5.87-6.6696.9497.05-53.61-68.8535.01-20,862.150.00--35.1567.7216.51--36.60--
Himacs Ltd18.21bn1.17bn16.21bn944.0012.881.2913.700.8902101.37101.371,581.111,015.731.36156.296.9419,291,310.008.709.5010.3511.6319.3319.966.406.975.18--0.0037.754.083.329.2113.228.4512.47
Members Co Ltd23.39bn867.20m16.34bn2.97k17.952.7911.370.698367.8167.811,830.52436.322.20166.227.337,884,742.008.177.3514.6512.6723.7026.043.714.331.51--0.111946.249.1016.05176.51-16.506.8317.98
Caica Digital Inc5.20bn166.79m17.05bn356.0078.884.2399.773.281.281.2837.9123.871.5513.395.8014,594,190.004.97-6.266.25-40.6617.0921.473.21-38.903.65--0.00---7.33-2.85444.37---71.13--
Cube System Inc18.46bn1.40bn17.06bn918.0011.691.4711.390.924192.6292.621,222.19736.181.32336.485.7820,106,750.009.999.0211.9011.2923.4421.217.586.124.31--0.020249.601.834.5318.1719.1484.1017.32
Cross Cat Co Ltd16.65bn1.42bn17.21bn856.009.992.2010.691.03101.27101.271,186.86459.011.74--3.9919,456,330.0014.8412.0119.9317.9023.4922.898.537.17----0.098338.168.4610.850.401621.60-12.0124.57
Segue Group Co Ltd22.66bn840.74m17.23bn709.0020.124.2413.180.760226.2926.29704.52124.811.314.975.1931,959,480.005.116.1816.2114.4024.0625.353.904.140.8565--0.441242.177.3114.18-23.144.29-0.582345.85
Japan Data Science Consortium Co Ltd22.79bn393.66m17.24bn163.0038.533.4031.540.756527.6927.691,621.36313.382.85--8.49139,821,300.005.400.30637.560.385510.5714.441.890.1601--11.080.22550.0040.09113.85224.17---13.33--
Sun* Inc14.53bn849.00m17.45bn2.05k20.721.6616.491.2021.5321.53367.75269.291.0388.008.237,092,774.006.0412.327.7715.1248.2050.775.8410.993.47--0.12230.008.4124.54-34.8020.0211.72--
R&D Computer Co Ltd13.19bn1.11bn17.50bn563.0015.782.8613.341.3361.7361.73734.83340.831.5968.945.1523,431,100.0013.4311.5717.1715.4623.3220.388.447.124.30--0.0048.68-0.01478.59-17.0616.6331.2334.00
Data as of Feb 06 2026. Currency figures normalised to Susmed Inc's reporting currency: Japanese Yen JPY

Institutional shareholders

7.14%Per cent of shares held by top holders
HolderShares% Held
SPARX Asset Management Co., Ltd.as of 31 Dec 2024868.30k5.15%
Nomura Asset Management Co., Ltd.as of 06 Dec 2024179.50k1.06%
Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 30 Jun 2025123.40k0.73%
Simplex Asset Management Co., Ltd.as of 08 Jan 202617.30k0.10%
Asset Management One Co., Ltd.as of 03 Sep 202516.00k0.10%
Chibagin Asset Management Co. Ltd.as of 30 May 20240.000.00%
Sumitomo Mitsui DS Asset Management Co., Ltd.as of 15 Oct 20250.000.00%
Amova Asset Management Co., Ltd.as of 18 Dec 20240.000.00%
More ▼
Data from 22 Jul 2025 - 29 Jan 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.